Aliss Tsz Ching Chang

Dr. Aliss Tsz Ching Chang

orcid

Research Focus & Metrics

Academic Career Length

4Years (2023-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
8 February 2023 in Cancers
Verified
Journal Article
Open access
PDF file
JCJoyce W.H. Chan
Joyce W.H. Chan
ISIvan C. H. Siu
Ivan C. H. Siu
ACAliss Tsz Ching Chang
Aliss Tsz Ching Chang
MLMolly S. C. Li
Molly S. C. Li
RLRainbow W.H. Lau
Rainbow W.H. Lau
Calvin NgCalvin Ng
Calvin Ng
The demand for parenchyma-sparing local therapies for lung cancer is rising owing to an increasing incidence of multifocal lung cancers and patients who are unfit for surgery. With the latest evidence of the efficacy of lung cancer screening, more premalignant or early-stage lung cancers are being discovered and the paradigm has shifted from treatment to prevention. Transbronchial therapy is an important armamentarium in the local treatment of lung cancers, with microwave ablation being the most promising based on early to midterm results. Adjuncts to improve transbronchial ablation efficiency and accuracy include mobile C-arm platforms, software to correct for the CT-to-body divergence, metal-containing nanoparticles, and robotic bronchoscopy. Other forms of energy including steam vapor therapy and pulse electric field are under intensive investigation.

12 February 2024 in Asian Cardiovascular and Thoracic Annals
Verified
Journal Article
Closed access
ACAliss Tsz Ching Chang
Aliss Tsz Ching Chang
JCJoyce Wing Yan Chan
Joyce Wing Yan Chan
ISIvan Chi Hin Siu
Ivan Chi Hin Siu
RLRainbow Wing Hung Lau
Rainbow Wing Hung Lau
Calvin NgCalvin Ng
Calvin Ng
Background: Transbronchial microwave ablation in treating lung nodules is gaining popularity. However, microwave ablation in subpleural lung nodules raised concerns about pleural-based complications due to the proximity between the pleura and the ablation zone. Methods: Patients who underwent transbronchial microwave ablation between March 2019 and November 2022 were included in this analysis. The lung nodules were categorized into the subpleural group—less than 5 mm distance to the nearest pleural surface; the deep nodule group—larger or equal to 5 mm distance to the nearest pleural surface. A review of the safety profile of subpleural lung nodule ablation was conducted. Results: Eighty-two lung nodules ( n = 82) from 77 patients were treated. The mean nodule size was 14.2 ± 5.50 mm. The technical success rate was 100%. The mean procedural time was 133 min. No statistically significant differences were detected in the complication rate and the length of stay between the subpleural and deep nodule groups. Complications occured in 21 nodules (25.6%). No minor pneumothorax was reported. Total five cases of pneumothorax required drainage were observed (6.06% in subpleural nodules [ n = 2] vs. 6.12% in deep nodules [ n = 3], p = 0.991). Total seven cases of pleuritic chest pain were observed (12.1% in subpleural nodules [ n = 4] vs. 6.12% in deep nodules [ n = 3], p = 0.340). Conclusions: This single-center retrospective analysis found no significant difference in the safety outcomes between subpleural and nonsubpleural lung nodule ablation. The overall rate of complications was low in the cohort. This demonstrated that transbronchial microwave was feasible and safe for most lung nodules.

1 April 2026
Verified
Journal Article
Open access
ACAliss Tsz Ching Chang
Aliss Tsz Ching Chang
CCCindy S Y Cho
Cindy S Y Cho
JCJoyce W Y Chan
Joyce W Y Chan
WLWei Liu
Wei Liu
RLRainbow W.H. Lau
Rainbow W.H. Lau
Calvin NgCalvin Ng
Calvin Ng
This case series aims to evaluate the incidence, mechanisms, and management of bronchopleural fistula (BPF) following transbronchial microwave ablation (TMWA) for lung tumours and to explore innovative strategies for prevention and treatment. A retrospective review was conducted on 173 patients who underwent 209 sessions of TMWA from March 2019 to May 2025 at a single centre. Four cases of BPF confirmed by imaging and clinical presentation were analysed. Data collected included procedural details, mechanisms of BPF formation, management strategies, and patient outcomes. Techniques such as intraoperative fibrin glue injection and endobronchial valve placement were documented. BPF occurred in 4 patients (1.9%) and was associated with mechanisms including extensive ablation zone with cavitation, tissue contraction, and inadvertent pleural puncture. Treatments varied from conservative drainage and antibiotics to targeted endobronchial interventions, with all BPF successfully resolved. The use of innovative techniques, such as intraoperative fibrin glue injection, demonstrated promising results with minimal invasiveness. Patients with BPF experienced longer hospital stays compared to those without complications. Although rare, BPF is a significant complication after TMWA, often requiring individualized management. Early recognition through vigilant monitoring and advanced imaging facilitates prompt intervention. Further prospective studies are needed to refine prevention and management strategies for this serious complication.

15 September 2025
Verified
Book Chapter
Open access
PDF file
ACAliss Tsz Ching Chang
Aliss Tsz Ching Chang
JCJoyce W.H. Chan
Joyce W.H. Chan
RLRainbow W.H. Lau
Rainbow W.H. Lau
JCJunko Ching Shun Chan
Junko Ching Shun Chan
WLWei Liu
Wei Liu
Calvin NgCalvin Ng
Calvin Ng
The landscape of lung cancer management is undergoing a transformative paradigm shift, shifting from the traditional focus on solitary tumors to the recognition and treatment of small, multifocal, ground-glass lesions—a change driven predominantly by the widespread adoption of low-dose computed tomography screening. These multifocal tumors pose unprecedented diagnostic and therapeutic challenges due to their minute size, often subsolid consistency, and complex distribution within the lung. To address these complexities, pioneering technological innovations have emerged to enhance lesion localization accuracy and elevate treatment precision. Among these, the advent of advanced navigation bronchoscopy stands out as a groundbreaking development, revolutionizing both diagnostic workflows and local ablation strategies, thereby fundamentally redefining the management of multifocal lung tumors. This approach has yielded remarkable clinical outcomes, characterized by superior efficacy and a highly favorable safety profile. Further elevating this field are integrations of robotic-assisted bronchoscopy, hybrid operating room, and artificial intelligence—collectively constituting a comprehensive, streamlined treatment pathway that aims to deliver a cohesive, minimally invasive, one-stop solution for lung cancer therapy. As these technologies continue to evolve, an array of innovative bronchoscopy systems and ablative modalities remain at the forefront of ongoing research and development. In this chapter, we will explore the transformative role of navigation bronchoscopy in lung cancer management, critically examine the latest technological breakthroughs, and project future directions poised to redefine therapeutic standards in this rapidly evolving domain.

24 September 2026 in Frontiers in Surgery
Verified
Journal Article
Open access
PDF file
ACAliss Tsz Ching Chang
Aliss Tsz Ching Chang
RLRainbow W. H. Lau
Rainbow W. H. Lau
JCJoyce W. Y. Chan
Joyce W. Y. Chan
WLWei Liu
Wei Liu
Calvin NgCalvin Ng
Calvin Ng
Background: The management of multifocal lung malignancies presents significant challenges, particularly when extensive resection may not be feasible due to limited pulmonary reserve. Thus, a hybrid management approach combining lung surgery with transbronchial local ablation has been developed to control local disease while minimizing lung parenchymal loss. We evaluated the safety, feasibility, and mid-term clinical outcomes of this hybrid approach in managing multifocal lung lesions. Methods: A retrospective single-center review was conducted of patients who underwent combined video-assisted thoracic surgery (VATS) lung resection and transbronchial microwave ablation (TMWA) in a hybrid operating room (HOR) between November 2019 and April 2026. Patient demographics, tumor characteristics, procedural details, perioperative complications, and mid-term clinical outcomes were reported, including intraoperative technical success, 30-day morbidity, overall survival, and rate of local recurrence. Results: Twenty-two patients (mean age 56.8 ± 11.8 years) with multifocal lung malignancies or suspicious multifocal lung nodules were discussed at a multidisciplinary team meeting. All twenty-two patients underwent 23 combined procedures. A total of 70 lesions were treated: 41 by VATS resection and 29 by TMWA. Technical success was achieved in 100% of procedures, as confirmed by intraoperative cone-beam computed tomography. The 30-day complication rate was 21.7%, with no procedure-related 30-day mortality. 20 patients have follow-up beyond 30 days (two patients were lost to follow-up). At a median follow-up of 24 months, the local control rate for ablated lesions was 96.6%, with local-recurrence-free survival of 95% and overall survival of 85%. Among the 41 resected lung lesions, 17 were multifocal lung adenocarcinoma, 22 were metastatic nodules, and two showed no evidence of malignancy. However, preoperative histopathological confirmation was available for only four ablated lesions, which showed either atypical pneumocytes or lung adenocarcinoma. Conclusions: Hybrid treatment combining VATS and TMWA is a safe and feasible approach for multifocal lung lesions, with reasonable complication rates and acceptable mid-term disease control. This hybrid technique may offer benefits in parenchymal preservation, particularly in patients with borderline lung function, while achieving reasonable local control.

8 April 2026 in Cancers
Verified
Journal Article
Open access
PDF file
WLWei Liu
Wei Liu
ACAliss Tsz Ching Chang
Aliss Tsz Ching Chang
JCJoyce W. Y. Chan
Joyce W. Y. Chan
CCChing Shun Junko Chan
Ching Shun Junko Chan
RLRainbow W.H. Lau
Rainbow W.H. Lau
Calvin NgCalvin Ng
Calvin Ng
Background/Objectives: Intrapulmonary metastasis (IPM) after an initial single primary lung cancer (SPLC) is an adverse follow-up pattern; however, when studying population-based longitudinal records, the determinants remain unclear. We aimed to identify factors associated with subsequent IPM after initial SPLC using artificial intelligence (AI)-driven analytical approaches. Methods: We used Surveillance, Epidemiology, and End Results (SEER) lung cancer records from 2000 to 2019. Adults with at least two records were restricted to those with SPLC at the first record. Outcome at the second record was registry-classified IPM versus persistent SPLC. A machine learning framework based on random forest models was developed using baseline variables, first record characteristics, and the interval between records. Temporal validation was performed by training on cases from 2000 to 2013 and testing on cases from 2014 to 2019. A dynamic Bayesian network (DBN) supported simulated intervention (SI) analyses to estimate model-implied risk ratios (RRs) with 95% confidence intervals (CIs). Results: Among 3450 patients, 361 had registry-classified IPM at the second record. The random forest model achieved an area under the curve (AUC) of 0.852 in internal validation and 0.929 in temporal validation. Surgery and record timing were the leading predictors. The DBN retained surgery as the only direct parent and achieved an AUC of 0.779. SI analyses showed higher IPM probability for pleural invasion level (PL) 3 versus PL 0, RR 1.378 (95% CI, 1.080–1.657). Lobectomy with mediastinal lymph node dissection versus wedge resection lowered the IPM probability, RR 0.378 (95% CI, 0.219–0.636). Conclusions: AI-based time-sequence modeling integrating machine learning and a DBN allowed for the identification of surgery, pleural invasion, and record timing as key factors associated with subsequent IPM classification after initial SPLC. This framework demonstrates the potential of combining predictive and probabilistic dependency modeling to investigate registry-based disease classification patterns, and may support hypothesis generation for future prospective studies.